Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 2005

View Archived Issues

Preclinical data on EP4 receptor agonist ONO-4819

LXR - a novel therapeutic target for MS

Endocannabinoid improves clinical scores in MS mice

Imatinib mesylate - a novel strategy for pulmonary hypertension/News in Context

ISIS-3082 prevents postoperative ileus in vivo

A role for Src in lung cancer

Beneficial use of NO boosting agents for atherosclerosis

Callisto and Institute of Hepatitis Viral Research collaborate on biowarfare vaccines

Avidex licenses diabetes target from King's College London

Angiotech completes acquisition of Afmedica

FDA issues health alert over Menactra

MorphoSys begins new therapeutic antibody programs with Schering

Alpharma to study abuse-resistant extended-release opioid in phase II study

Enrollment makes good progress in phase IIb colorectal cancer study of CoFactor

Agensys and sanofi pasteur collaborate on colorectal and prostate cancer vaccines

M-Vax for melanoma launched in Switzerland

Blopress receives Japanese approval for chronic heart failure

Banyu obtains Japanese import approval for Propecia

Recent patents report new treatments for respiratory disorders

Purdue Research Foundation patents novel diagnostic agents

Recent patents describe novel antiinfective agents

Extension studies of asoprisnil to be amended

Cannabis-based medicine reduces central pain scores in MS patients

Good safety profile found for topical pimecrolimus in infants with atopic dermatitis

Snapshots on studies reported at the 2005 ASBMR and NAMS meetings

Eszopiclone shows efficacy in insomnia associated with menopause

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...